KPV

KPV (Lys-Pro-Val) is a short tripeptide derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). In research settings, it has been studied primarily for its potential anti-inflammatory and immunomodulatory properties.

Preclinical investigations suggest KPV may influence inflammatory signaling pathways, including modulation of cytokine activity and NF-κB–related mechanisms. Laboratory models have explored its effects in gastrointestinal, dermatological, and systemic inflammation contexts.